Olaparib (AZD2281)

olaparib · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olaparib (AZD2281), covering 2013-03-11 to 2013-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer [Phase 2]